James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.
What is James T. Treace's net worth?
The estimated net worth of James T. Treace is at least $8.52 million as of August 15th, 2024. Mr. Treace owns 1,223,441 shares of Treace Medical Concepts stock worth more than $8,515,149 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Treace may own. Learn More about James T. Treace's net worth.
How do I contact James T. Treace?
Has James T. Treace been buying or selling shares of Treace Medical Concepts?
James T. Treace has not been actively trading shares of Treace Medical Concepts in the last ninety days. Most recently, on Thursday, August 15th, James T. Treace bought 84,000 shares of Treace Medical Concepts stock. The stock was acquired at an average cost of $5.96 per share, with a total value of $500,640.00. Following the completion of the transaction, the director now directly owns 1,223,441 shares of the company's stock, valued at $7,291,708.36. Learn More on James T. Treace's trading history.
Who are Treace Medical Concepts' active insiders?
Are insiders buying or selling shares of Treace Medical Concepts?
During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. The most recent insider tranaction occured on September, 16th when CEO John T Treace bought 50,000 shares worth more than $265,500.00. Insiders at Treace Medical Concepts own 24.4% of the company.
Learn More about insider trades at Treace Medical Concepts. Information on this page was last updated on 9/16/2024.